MedPath

LINGDANWANG CAPSULE

LINGDANWANG CAPSULE

Discontinued
DIN Number

02238329

Drug Class

Human

Market Date

N/A

Company
HC

sucan international trading company

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02238329
AIG Number0333940001
Classification & Schedule
C
Drug Class
Human
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
Health Canada Classification

ACTIVE INGREDIENTS (3)

GANODERMA LUCIDUMActive
Strength: 110 MG
Monograph: GANODERMA LUCIDUM
GINSENGActive
Strength: 110 MG
Monograph: GINSENG
RHIZOMA ATRACTYLODISActive
Strength: 115 MG
Monograph: RHIZOMA ATRACTYLODIS

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.